Acadia Investors Get Class Cert. In Suit Over Parkinson's Drug

By Bonnie Eslinger · March 11, 2024, 10:55 PM EDT

A California federal judge on Monday certified a class of Acadia Pharmaceuticals investors in a lawsuit accusing the company of making false and misleading statements regarding the likelihood that its Parkinson's...

To view the full article, register now.